ホーム › がん（全種類） › テキサス › Houston
Houston、TXにおけるがん（全種類）の臨床試験
Houstonとその周辺地域（約30マイル以内）の拠点で、がん（全種類）に関する121件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
被験者募集中第1相
- The University of Texas - MD Anderson Cancer Center, Houston
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
被験者募集中観察研究
- The University of Texas M.D. Anderson Cancer Center, Houston
A Study of PHN-012 in Patients With Advanced Solid Tumors
被験者募集中第1相
- PHN-012-001 Site, Houston
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
被験者募集中第1相
- MD Anderson Cancer Center, Houston
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
被験者募集中第3相
- Investigative Site, Houston
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
被験者募集中第3相
- Oncology Consultants PA, Houston
- University of Texas MD Anderson Cancer Center, Houston
A Study of JNJ-1761981 in Participants With Solid Tumors
被験者募集中第1相
- MD Anderson Cancer Center, Houston
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
被験者募集中第2相
- Baylor College of Medicine Medical Center ( Site 0004), Houston
- Harris Health System ( Site 0040), Houston
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
被験者募集中第2/3相
- Houston Methodist Hospital, Houston
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
被験者募集中第1相
- MD Anderson Cancer Center, Houston
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
被験者募集中第1相
- MD Anderson Cancer Center, Houston
- NEXT Oncology, Houston
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
被験者募集中第1/2相
- University of Texas M.D. Anderson Cancer Center ( Site 4007), Houston
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
被験者募集中第1相
- MD Anderson Cancer Center, Houston
Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life
被験者募集中
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
被験者募集中第3相
- Houston Methodist Cancer Center, Houston
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
被験者募集中第3相
- Quetzal Site 6, Houston
Intratumoral N17350 in Advanced Solid Tumors
被験者募集中第1/2相
- The University of Texas MD Anderson Cancer Center, Houston
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
被験者募集中第3相
- The University of Texas MD Anderson Cancer Center /ID# 280070, Houston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
被験者募集中第1/2相
- MD Anderson, Houston
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
被験者募集中第2相
- The University of Texas MD Anderson Cancer Center, Houston
Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions
被験者募集中観察研究
- UT MD Anderson Cancer Center, Houston
Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.
被験者募集中観察研究
- M D Anderson Cancer Center, Houston
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
被験者募集中第2/3相
- The University of Texas Health Science Center at Houston, Houston
- University of Texas- MD Anderson, Houston
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
被験者募集中第1/2相
- University of Texas-MD Anderson Cancer Center ( Site 3007), Houston
Statins to Prevent Cancer Associated Blood Clots
被験者募集中第4相
- The University of Texas MD Anderson Cancer Center, Houston
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
被験者募集中第2相
- The University of Texas MD Anderson Cancer Center, Houston
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
被験者募集中第2相
- The University of Texas M. D. Anderson Cancer Center, Houston
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
被験者募集中第1/2相
- Research Site, Houston
A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
被験者募集中第1相
- Houston Methodist Hospital ( Site 0103), Houston
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
被験者募集中第1/2相
- The University of Texas Md Anderson Cancer Center, Houston
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
被験者募集中第1/2相
- NEXT Oncology ( Site 1011), Houston
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
被験者募集中第1相
- Investigational Site Number: 401, Houston
A Phase 1/1b Study of IAM1363 in HER2 Cancers
被験者募集中第1相
- MD Anderson Cancer Center - University of Texas, Houston
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
被験者募集中第1相
- UT MD Anderson, Houston
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
被験者募集中第1/2相
- University of Texas MD Anderson Cancer Center, Houston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
被験者募集中第3相
- Houston Methodist Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
- Lumi Research, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
被験者募集中第1相
- MD Anderson Cancer Center, Houston
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
被験者募集中第2相
- M D Anderson Cancer Center, Houston
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
被験者募集中第2相
- Kelsey-Seybold Clinic, Houston
A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess the Safety and Quality of Life Benefits of Computer-assisted Vacuum Thrombectomy (CAVT) in the Treatment of Cancer Patients With Intermediate Risk Pulmonary Embolism (PE)
被験者募集中
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
被験者募集中第1相
- The University of Texas MD Anderson Cancer Center, Houston
PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System
被験者募集中
- The University of Texas M. D. Anderson Cancer Center, Houston
Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
被験者募集中第2相
- M D Anderson Cancer Center, Houston
ORB-021 In Patients With Advanced Solid Tumors
被験者募集中第1相
- MDAC, Houston
Project: Every Child for Younger Patients With Cancer
被験者募集中観察研究
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- UT MD Anderson Cancer Center, Houston
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
被験者募集中第3相
- Houston Metro Urology, Houston
Abatacept in Immune Checkpoint Inhibitor Myocarditis
被験者募集中第3相
- MD Anderson Cancer Center, Houston
FOG-001 in Locally Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- The University of Texas MD Anderson Cancer Center, Houston
Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers
被験者募集中
- MD Anderson, Houston
Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer
被験者募集中観察研究
- The University of Texas M. D. Anderson Cancer Center, Houston
Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms
被験者募集中第1相
- The University of Texas M. D. Anderson Cancer Center, Houston
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
被験者募集中第2相
- The University of Texas M. D. Anderson Cancer Center, Houston
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
被験者募集中
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- The University of Texas, MD Anderson Cancer Center, Houston
Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
被験者募集中第2相
- M D Anderson Cancer Center, Houston
Examining the Feasibility and Impact of a Clinic-based Food Farmacy and Digital Culinary Medicine Program Among Cancer Survivors Treated in a Safety Net Hospital
被験者募集中
- The University of Texas M. D. Anderson Cancer Center, Houston
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
被験者募集中第2相
- Texas Childrens Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
被験者募集中第3相
- Houston Methodist Hospital, Houston
- Memorial Hermann Texas Medical Center, Houston
- Methodist Willowbrook Hospital, Houston
- 他1件
IDOV-Immune for Advanced Solid Tumors
被験者募集中第1相
- MD Anderson Cancer Center, Houston
New Assessment System in Measuring Symptom Distress in Cancer Patients
被験者募集中観察研究健康なボランティア歓迎
- M D Anderson Cancer Center, Houston
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
被験者募集中第2相
- MD Anderson Cancer Center, Houston
Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer
被験者募集中健康なボランティア歓迎
- MD Anderson Cancer Center, Houston
Decoupling Immunotherapy Toxicity and Cancer Response
被験者募集中観察研究
- The University of Texas M. D. Anderson Cancer Center, Houston
A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients
被験者募集中第3相
- M D Anderson Cancer Center, Houston
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
被験者募集中
- M D Anderson Cancer Center, Houston
Long-Term Follow-Up of Recipient of Gene Transfer Research
被験者募集中観察研究健康なボランティア歓迎
- University of Texas MD Anderson Cancer Center, Houston
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
被験者募集中第1相
- Oncology Consultants /ID# 268323, Houston
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
被験者募集中第2相
- The University of Texas MD Anderson Cancer Center /ID# 273539, Houston
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- University of Texas MD Anderson Cancer Center, Houston
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
被験者募集中第1/2相
- The University of Texas MD Anderson Cancer Center, Houston
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
被験者募集中第1/2相
- The University of Texas MD Anderson Cancer Center, Houston
Molecular Genetics Studies of Cancer Patients and Their Relatives
被験者募集中観察研究健康なボランティア歓迎
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- The University of Texas MD Anderson Cancer Center, Houston
A Multi Center Study of Sexual Toxicities After Radiotherapy
被験者募集中観察研究
- M.D. Anderson Cancer Center, Houston
Childhood Cancer Survivor Study
被験者募集中観察研究健康なボランティア歓迎
- M.D. Anderson Cancer Center, Houston
- Texas Children's Hospital, Houston
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
被験者募集中
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
被験者募集中第1相
- Research Site, Houston
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
被験者募集中第2/3相
- The University of Texas MD Anderson Cancer Center /ID# 275107, Houston
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
被験者募集中第1相
- University of Texas MD Anderson Cancer Center /ID# 252004, Houston
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
被験者募集中第1相
- The University of Texas MD Anderson Cancer Center, Houston
Active Living After Cancer: Implementation Within Be Well Acres Homes
被験者募集中
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
被験者募集中第1/2相
- MD Anderson Cancer Center, Houston
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
被験者募集中第1/2相
- University of Texas MD Anderson Cancer Center, Houston
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
被験者募集中第1相
- MDACC, Houston
Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma
被験者募集中第1/2相
- M D Anderson Cancer Center, Houston
Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers
被験者募集中第2/3相
- MD Anderson Cancer Centerr, Houston
A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients
被験者募集中第2相
- The University of Texas MD Anderson Cancer Center, Houston
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
被験者募集中第1/2相
- MD Anderson Cancer Center, Houston
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
被験者募集中第2相
- University of Texas MD Anderson Cancer Center, Houston
Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors
被験者募集中観察研究
- M D Anderson Cancer Center, Houston
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
被験者募集中第1相
- MD Anderson Cancer Center, Houston
Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic
被験者募集中観察研究
- MD Anderson Cancer Center, Houston
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
被験者募集中第1/2相
- The University of Texas MD Anderson Cancer Center, Houston
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
被験者募集中第1相
- University of Texas MD Anderson Cancer Center, Houston
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
被験者募集中第2相
- M D Anderson Cancer Center, Houston
The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care
被験者募集中観察研究健康なボランティア歓迎
- Grace Clinic, Houston
Suprachoroidal Administration in Subjects With Metastases to the Choroid
被験者募集中第2相
- Retina Consultants of Texas, Bellaire · 7マイル先
Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
被験者募集中第2相
- Houston Methodist Neal Cancer Center, Houston
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
被験者募集中観察研究
- Md Anderson Cancer Center, Houston
Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States
被験者募集中第2相
- Baylor St. Luke's Medical Center, Houston
- Ben Taub Hospital (Harris Health Systems), Houston
Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States
被験者募集中
- M D Anderson Cancer Center, Houston
Primary Tumor Research and Outcomes Network
被験者募集中観察研究
- The University of Texas M.D. Anderson Cancer Center, Houston
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
被験者募集中
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A Study of YL242 in Subjects With Advanced Solid Tumors
被験者募集中第1/2相
- US-203, Houston
Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies
被験者募集中第3相
- Houston Methodist Neal Cancer Center, Houston
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
被験者募集中第1相
- The University of Texas MD Anderson Cancer Center, Houston
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
被験者募集中第2相
- MD Anderson Cancer Center, Houston
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
被験者募集中観察研究
- MD Anderson Cancer Center, Houston
- Texas Children's Hospital, Houston
Childhood Cancer Predisposition Study (CCPS)
被験者募集中観察研究
- Baylor College of Medicine, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Houston
A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
被験者募集中観察研究健康なボランティア歓迎
- Oncology Consultants, P.A., Houston
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
被験者募集中
- Baylor College of Medicine- McNair Campus, Houston
- Baylor College of Medicine, Houston
- Ben Taub General Hospital, Houston
- 他1件
Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma
被験者募集中第2相
- The University of Texas Health Science Center at Houston, Houston
A Study of NX-1607 in Adults With Advanced Malignancies
被験者募集中第1相
- MD Anderson Cancer Center, Houston
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- MD Anderson Cancer Center, Houston
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
被験者募集中第1/2相
- The University of Texas MD Anderson Cancer Center, Houston
Trial of DFP-14927 in Advanced Solid Tumors
被験者募集中第1相
- MD Anderson Cancer Center, Houston
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
被験者募集中第1/2相
- Oncology Consultants, P.A., Houston
- The University of Texas M. D. Anderson Cancer Center, Houston
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
被験者募集中
- The University of Texas MD Anderson Cancer Center, Houston
HPV Vaccine, Imiquimod, and Metformin Combination Trial
被験者募集中第2相
- Baylor St. Luke's Medical Center- Dan L. Duncan Comprehensive Cancer Center, Houston
- Harris Health Smith Clinic, Houston
A Study in Patients With Advanced Cancers
被験者募集中第1/2相
- University of Texas MD Anderson Cancer Center, Houston
他の都市におけるがん（全種類）の試験
- New York City, NY110件の研究
- Boston, MA86件の研究
- Los Angeles, CA73件の研究
- Nashville, TN65件の研究
- Philadelphia, PA59件の研究
- Durham, NC58件の研究
- Washington, DC58件の研究
- Chicago, IL51件の研究
- Seattle, WA49件の研究
- Atlanta, GA49件の研究
- Arlington, VA48件の研究
- St. Louis, MO46件の研究
Houstonにおける他の研究
- 非小細胞肺癌145件の研究
- 乳がん126件の研究
- 転移性癌104件の研究
- 大腸癌102件の研究
- 卵巣がん89件の研究
- 急性骨髄性白血病85件の研究
- 肺がん78件の研究
- 前立腺がん76件の研究
- 子宮内膜がん68件の研究
- 膵臓がん61件の研究
- 悪性黒色腫59件の研究
- 頭頸部扁平上皮癌47件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。